BIOCON PHARMA LIMITED

BIOCON PHARMA LIMITED is primarily a manufacturer.

Company Introduction:

Biocon Limited, an Indian biopharmaceutical company headquartered in Bengaluru, India, is a globally recognized entity in the field of biotechnology and pharmaceuticals. Founded by Kiran Mazumdar-Shaw, the company has grown to become a leading innovator in the development and manufacturing of biopharmaceuticals.

Biocon's core business involves the research, development, and large-scale manufacturing of a diverse portfolio of products. This includes biosimilars, novel biologics, and certain generic formulations, with a strong focus on therapeutic areas such as diabetes, oncology, and immunology. The company operates extensive, state-of-the-art manufacturing facilities capable of producing complex biological molecules and pharmaceutical dosages for global markets.

Biocon's operations span the entire drug development lifecycle, from drug discovery and clinical development to regulatory approvals and commercialization. Its commitment to providing affordable access to life-saving and life-enhancing medicines has positioned it as a significant player in the global biopharmaceutical industry.

Here are some of the products manufactured or marketed by BIOCON PHARMA LIMITED (India):

* **Biosimilars:** Insulin Glargine, Trastuzumab, Pegfilgrastim, Adalimumab, Bevacizumab

* **Generics:** Rosuvastatin, Atorvastatin, Esomeprazole

* **Novel Biologics:** Alzumab

* **Formulations:** A variety of formulations across therapeutic areas like diabetes, oncology, and immunology.

* **API (Active Pharmaceutical Ingredients):** Statins, immunosuppressants, and other APIs.